Glucotrack (GCTK) Cash from Investing Activities Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | -528.34% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | -4.51% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | -82.56% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 40.11% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | - |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | -6.30% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | -420.31% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | -104.07% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | -14.95% |
| 10 | Glucotrack | 290,858.33 | -7.09 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -103.03% |
| Mar 31, 2025 | 84.75% |
| Dec 31, 2022 | 225.00% |
| Dec 31, 2021 | 42.86% |
| Dec 31, 2020 | -1,469.51% |
| Sep 30, 2020 | -145.23% |
| Mar 31, 2020 | -135.18% |
| Dec 31, 2019 | -105.37% |
| Sep 30, 2019 | -7.52% |
| Jun 30, 2019 | -260.35% |
| Mar 31, 2019 | -585.07% |
| Sep 30, 2018 | 19.57% |
| Jun 30, 2018 | 70.91% |
| Mar 31, 2018 | 36.97% |
| Sep 30, 2017 | 49.37% |
| Jun 30, 2017 | 84.97% |
| Mar 31, 2017 | 93.83% |
| Sep 30, 2016 | 61.92% |
| Jun 30, 2016 | 27.76% |
| Mar 31, 2016 | -97.89% |
| Sep 30, 2015 | -139.76% |
| Jun 30, 2015 | 20.48% |
| Mar 31, 2015 | -36.72% |
| Sep 30, 2014 | -105.03% |
| Jun 30, 2014 | 48.25% |
| Mar 31, 2014 | -1,026.46% |
| Dec 31, 2013 | -186.06% |
| Sep 30, 2013 | -360.42% |
| Jun 30, 2013 | -1,467.82% |
| Mar 31, 2013 | 94.93% |
| Dec 31, 2012 | -115.02% |
| Sep 30, 2012 | 66.56% |
| Jun 30, 2012 | 112.03% |
| Mar 31, 2012 | -14.08% |
| Dec 31, 2011 | 1,171.14% |